Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability
Synergy CHC Corp (NASDAQ:SNYR) reported strong Q2 2025 financial results, marking its tenth consecutive quarter of profitability. The company achieved revenue of $8.1 million (up 1% YoY), with improved gross margin of 76.7% (vs 69.5%) and net income of $1.5 million (up 125% YoY). Earnings per share increased to $0.17 (up 86% YoY).
Key developments include a $20 million debt refinancing with ACP Agency, expansion of FOCUSfactor's international presence through a licensing agreement in Turkey, and significant North American retail and distribution wins. The company's working capital position improved to a $12.4 million surplus from a previous $1.12 million deficit, while EBITDA grew to $3.80 million (up 136% YoY).
Synergy CHC Corp (NASDAQ:SNYR) ha riportato solidi risultati finanziari per il secondo trimestre 2025, segnando il decimo trimestre consecutivo di redditività. La società ha registrato ricavi per $8.1 milioni (in aumento dell'1% su base annua), con un margine lordo migliorato al 76.7% (da 69.5%) e un utile netto di $1.5 milioni (in crescita del 125% rispetto all'anno precedente). L'utile per azione è salito a $0.17 (in aumento dell'86% su base annua).
Tra gli sviluppi principali figurano un rifinanziamento del debito da $20 milioni con ACP Agency, l'espansione internazionale di FOCUSfactor tramite un accordo di licenza in Turchia e importanti successi nella distribuzione e nel retail in Nord America. La posizione di capitale circolante è passata da un precedente disavanzo di $1.12 milioni a un surplus di $12.4 milioni, mentre l'EBITDA è salito a $3.80 milioni (in aumento del 136% su base annua).
Synergy CHC Corp (NASDAQ:SNYR) presentó sólidos resultados financieros en el segundo trimestre de 2025, marcando su décimo trimestre consecutivo de rentabilidad. La compañía alcanzó ingresos de $8.1 millones (suben 1% interanual), con un margen bruto mejorado al 76.7% (frente al 69.5%) y una utilidad neta de $1.5 millones (aumento del 125% interanual). Las ganancias por acción aumentaron a $0.17 (suben 86% interanual).
Entre los hitos clave se incluye un refinanciamiento de deuda por $20 millones con ACP Agency, la expansión internacional de FOCUSfactor mediante un acuerdo de licencia en Turquía y significativos logros en retail y distribución en Norteamérica. La posición de capital de trabajo mejoró de un déficit previo de $1.12 millones a un superávit de $12.4 millones, mientras que el EBITDA creció hasta $3.80 millones (aumento del 136% interanual).
Synergy CHC Corp (NASDAQ:SNYR)는 2025년 2분기에 견조한 실적을 발표하며 10분기 연속 흑자를 기록했습니다. 회사는 매출액 $8.1 million(전년 동기 대비 1% 증가), 개선된 총이익률 76.7%(이전 69.5% 대비), 그리고 $1.5 million의 순이익(전년 동기 대비 125% 증가)을 달성했습니다. 주당순이익은 $0.17(전년 동기 대비 86% 증가)으로 상승했습니다.
주요 성과로는 ACP Agency와의 $20 million 규모 부채 재융자, 터키에서의 라이선스 계약을 통한 FOCUSfactor의 해외 진출 확대, 북미에서의 유통 및 소매 채널 확보 등이 있습니다. 운전자본은 이전의 $1.12 million 적자에서 $12.4 million 흑자로 개선되었고, EBITDA는 $3.80 million(전년 동기 대비 136% 증가)으로 성장했습니다.
Synergy CHC Corp (NASDAQ:SNYR) a publié de solides résultats pour le deuxième trimestre 2025, enregistrant son dixième trimestre consécutif de rentabilité. La société a réalisé un chiffre d'affaires de $8.1 million (en hausse de 1% en glissement annuel), avec une marge brute améliorée à 76.7% (contre 69.5%) et un résultat net de $1.5 million (en hausse de 125% en glissement annuel). Le bénéfice par action a atteint $0.17 (en hausse de 86% en glissement annuel).
Parmi les faits marquants : un refinancement de dette de $20 million avec ACP Agency, l'expansion internationale de FOCUSfactor via un accord de licence en Turquie, ainsi que des gains importants en distribution et retail en Amérique du Nord. La trésorerie d'exploitation est passée d'un déficit antérieur de $1.12 million à un excédent de $12.4 million, tandis que l'EBITDA a augmenté pour atteindre $3.80 million (en hausse de 136% en glissement annuel).
Synergy CHC Corp (NASDAQ:SNYR) veröffentlichte starke Finanzergebnisse für das 2. Quartal 2025 und verzeichnet damit das zehnte Quartal in Folge mit Gewinn. Das Unternehmen erzielte Umsatzerlöse von $8.1 million (plus 1% gegenüber dem Vorjahr), eine verbesserte Bruttomarge von 76.7% (vs. 69.5%) und einen Nettoertrag von $1.5 million (plus 125% im Jahresvergleich). Der Gewinn je Aktie stieg auf $0.17 (plus 86% gegenüber dem Vorjahr).
Zu den wichtigsten Entwicklungen zählen eine $20 million Schuldenrefinanzierung mit ACP Agency, die internationale Expansion von FOCUSfactor durch eine Lizenzvereinbarung in der Türkei sowie bedeutende Erfolge im nordamerikanischen Einzelhandel und Vertrieb. Das Working Capital verbesserte sich von einem früheren Fehlbetrag von $1.12 million zu einem $12.4 million Überschuss, während das EBITDA auf $3.80 million anwuchs (plus 136% im Jahresvergleich).
- Net income increased by 125% year-over-year to $1.5 million
- Gross margin improved significantly to 76.7% from 69.5%
- EBITDA grew 136% to $3.80 million compared to $1.61 million in Q2 2024
- Working capital improved from -$1.12M deficit to $12.4M surplus
- Secured $20M term loan agreement enhancing financial flexibility
- Expanded international presence through new Turkish licensing deal
- Achieved significant North American retail and distribution wins
- Revenue growth was modest at only 1% year-over-year
- Operating expenses increased 16% to $4.6 million
- Cash used in operating activities was $899.7 thousand for H1 2025
- Interest expense increased significantly to $2.11M from $0.74M
Insights
Synergy CHC Corp delivered strong Q2 2025 results with significant net income growth (125%) and continued profitability amid strategic expansion.
Synergy CHC Corp's Q2 2025 results demonstrate continued financial strength with their tenth consecutive quarter of profitability. Revenue showed modest growth of
Net income surged
The balance sheet shows significant improvement with cash position increasing to
The
Operating expenses increased
The expansion of FOCUSfactor into Turkey through licensing agreements and new North American distribution partnerships positions the company for accelerated growth in late 2025. The substantial inventory increase (
WESTBROOK, Maine, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health and wellness company, is announcing its financial results for the three months ended June 30, 2025.
“We are pleased to report another strong quarter, marking our tenth consecutive quarter of profitability,” said Jack Ross, CEO of Synergy. “Revenue, gross profit, net income and earnings per share all grew year-over-year, reflecting our continued focus on disciplined execution and profitable growth.”
“We also made significant progress across our strategic priorities, including expanding the global footprint of our FOCUSfactor brand through a licensing agreement in Turkey. On the beverage side, our new leadership team is already driving results, securing distribution partners across North America and advancing the growth of our RTD business. In addition, we successfully completed a
Second Quarter 2025 Financial Summary vs. Same Year-Ago Period
- Revenue of
$8.1 million vs.$8.0 million . - Gross margin of
76.7% vs.69.5% . - Income from operations of
$1.62 million vs.$1.58 million . - Net income of
$1.5 million vs.$655.2 thousand . - Earnings per share of
$0.17 vs.$0.09 . - EBITDA, a non-GAAP financial measure, was
$3.80 million vs.$1.61 million .
Recent Business Highlights
- Synergy recently announced a series of major North American retail and distribution wins across its FOCUSfactor supplement and beverage lines, significantly expanding availability across mass, grocery, pharmacy, convenience and wholesale channels, which should start yielding significant results in the fourth quarter of 2025.
- On June 18, 2025, Synergy announced the expansion of its international licensing deal with Gravity Pharma, adding Turkey alongside the United Arab Emirates (UAE) for exclusive distribution of FOCUSfactor.
- On June 4, 2025, Synergy announced that it entered into a
$20 million term loan credit agreement, due May 2029, with ACP Agency, LLC, of which$17.5 million has been drawn. - During the second quarter, Synergy announced the additions of key individuals to drive the Company’s beverage growth.
- During the second quarter, the Company reduced outstanding liabilities by
$869 thousand . - Subsequent to the quarter end, Synergy reduced outstanding notes payable by
$1.8 million .
Second Quarter 2025 Financial Results
Revenue in the second quarter of 2025 was
Gross margin in the second quarter of 2025 was
Operating expenses in the second quarter of 2025 were
Income from operations for the second quarter of 2025 was
Net income in the second quarter of 2025 was
Earnings per share in the second quarter was
EBITDA (a non-GAAP financial measure) in the second quarter of 2025 was
Balance Sheet and Cash Flow
As of June 30, 2025, Synergy had approximately
As of June 30, 2025, Synergy had a working capital surplus of
As of June 30, 2025, Synergy had
Cash used in operating activities for the six months ended June 30, 2025 was
Non-GAAP Financial Measure Reconciliation: EBITDA
To assist financial statement users in an assessment of our historical performance, the Company discloses non-GAAP financial measures in press releases and on investor conference calls and related events, as the Company believes that the non-GAAP information enhances investors' overall understanding of our financial performance, and should be read in addition to, rather than instead of, the financial statements prepared in accordance with GAAP.
Management believes EBITDA provides useful information to investors by excluding certain items that may not be indicative of the Company’s core operating results and that can vary significantly between periods. EBITDA is defined as net income plus interest expense, income tax expense, depreciation and amortization.
The following table reconciles net income to EBITDA (in millions of US dollars):
| 3 Months ended June 30 | ||||
| 2025 | 2024 | |||
| Net income for the period | $1.47 | $0.66 | ||
| Adjusted for: | ||||
| Interest expense, net | 2.11 | 0.74 | ||
| Amortization of intangible assets | 0.03 | 0.03 | ||
| Tax expense | 0.19 | 0.18 | ||
| EBITDA | ||||
Conference Call
In conjunction with this announcement, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT on August 14, 2025 with the Company’s Chief Executive Officer, Jack Ross, and the Company’s Chief Financial Officer, Jaime Fickett. A live webcast of the call will be available on the Investor Relations section of Synergy’s website. To access the call by phone, please register here and you will be provided with dial in details. To avoid delays, we encourage participants to dial into the conference call 15 minutes ahead of the scheduled start time. A replay of the webcast will also be available for a limited time on the Company’s website.
About Synergy CHC Corp.
Synergy CHC Corp. is a provider of consumer health and wellness products. Its brand portfolio includes two flagship names: FOCUSfactor, a clinically studied brain health supplement shown to improve memory, concentration, and focus; and Flat Tummy, a lifestyle brand offering nutritional solutions designed to support women's wellness and weight management goals.
Forward Looking Statements
Certain statements contained in this press release constitute "forward-looking statements," including statements regarding expansion and growth initiatives, refinancing of our indebtedness and our free cash flow. These forward-looking statements represent Synergy's expectations or beliefs concerning future events, and it is possible that the results described in this press release will not be achieved. These forward-looking statements are subject to risks, uncertainties and other factors, which are set forth in Synergy's registration statement on Form S-1, as amended, many of which are outside of Synergy's control, that could cause actual results to differ materially from the results discussed in the forward-looking statements.
Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, Synergy does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Synergy to predict all such factors. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements in Synergy’s filings with the SEC. The risk factors and other factors noted in Synergy's filings could cause its actual results to differ materially from those contained in any forward-looking statement.
Investor Relations
Gateway Group
Cody Slach, Greg Robles
949.574.3860
SNYR@gateway-grp.com
| Synergy CHC Corp. | ||||||||
| Condensed Consolidated Balance Sheets | ||||||||
| June 30, | December 31, | |||||||
| 2025 | 2024 | |||||||
| (unaudited) | ||||||||
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | $ | 1,458,561 | $ | 687,920 | ||||
| Restricted cash | 100,000 | 100,000 | ||||||
| Accounts receivable, net | 7,069,889 | 5,321,037 | ||||||
| Other receivables | 2,025,094 | 1,999,637 | ||||||
| Loan receivable (related party) | 4,427,883 | 4,375,059 | ||||||
| Prepaid expenses (including related party amount of | 2,064,094 | 1,859,563 | ||||||
| Inventory, net | 2,364,158 | 1,716,552 | ||||||
| Total Current Assets | 19,509,679 | 16,059,768 | ||||||
| Intangible assets, net | 216,667 | 283,333 | ||||||
| Total Assets | $ | 19,726,346 | $ | 16,343,101 | ||||
| Liabilities and Stockholders’ Deficit | ||||||||
| Current Liabilities: | ||||||||
| Accounts payable and accrued liabilities (including payable to shareholder of | $ | 4,960,331 | $ | 5,191,868 | ||||
| Income taxes payable | 266,472 | 242,977 | ||||||
| Contract liabilities | 4,887 | 24,252 | ||||||
| Short term loans payable, net of debt discount | 1,894,857 | 7,725,272 | ||||||
| Current portion of long-term notes payable, net of debt discount and debt issuance cost, shareholder | - | 4,000,000 | ||||||
| Total Current Liabilities | 7,126,547 | 17,184,369 | ||||||
| Long-term Liabilities: | ||||||||
| Notes payable, net of debt discount, shareholder | - | 8,333,053 | ||||||
| Notes payable, net of debt discount | 24,978,999 | 7,457,022 | ||||||
| Total long-term liabilities | 24,978,999 | 15,790,075 | ||||||
| Total Liabilities | 32,105,546 | 32,974,444 | ||||||
| Commitments and contingencies | ||||||||
| Stockholders’ Deficit: | ||||||||
| Common stock, | 96 | 87 | ||||||
| Additional paid in capital | 29,508,354 | 27,643,660 | ||||||
| Accumulated other comprehensive loss | (9,838 | ) | (47,777 | ) | ||||
| Accumulated deficit | (41,750,312 | ) | (44,099,813 | ) | ||||
| Less: Treasury stock (180,073 shares) at cost | (127,500 | ) | (127,500 | ) | ||||
| Total stockholders’ deficit | (12,379,200 | ) | (16,631,343 | ) | ||||
| Total Liabilities and Stockholders’ Deficit | $ | 19,726,346 | $ | 16,343,101 | ||||
| Synergy CHC Corp. | ||||||||||||||||
| Unaudited Condensed Consolidated Statements of Income and Comprehensive Income | ||||||||||||||||
| For the three months ended | For the six months ended | |||||||||||||||
| June 30, | June 30, | June 30, | June 30, | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Revenue | ||||||||||||||||
| Product Sales | $ | 6,734,996 | $ | 8,024,840 | $ | 13,405,530 | $ | 17,436,703 | ||||||||
| License Revenue | 1,400,000 | - | 2,900,000 | - | ||||||||||||
| Total Revenue | 8,134,996 | 8,024,840 | 16,305,530 | 17,436,703 | ||||||||||||
| Cost of sales | 1,896,391 | 2,448,890 | 3,902,904 | 5,086,029 | ||||||||||||
| Gross profit | 6,238,605 | 5,575,950 | 12,402,626 | 12,350,674 | ||||||||||||
| Operating expenses | ||||||||||||||||
| Selling and marketing | 3,062,211 | 3,055,186 | 5,938,482 | 6,639,863 | ||||||||||||
| General and administrative | 1,519,325 | 903,838 | 2,826,039 | 2,252,223 | ||||||||||||
| Depreciation and amortization | 33,334 | 33,334 | 66,667 | 66,667 | ||||||||||||
| Total operating expenses | 4,614,870 | 3,992,358 | 8,831,188 | 8,958,753 | ||||||||||||
| Income from operations | 1,623,735 | 1,583,592 | 3,571,438 | 3,391,921 | ||||||||||||
| Other (income) expenses | ||||||||||||||||
| Other income | ||||||||||||||||
| Interest income | (379 | ) | (374 | ) | (14,261 | ) | (761 | ) | ||||||||
| Interest expense | 2,107,714 | 745,528 | 3,203,083 | 1,855,508 | ||||||||||||
| Gain on settlement of notes payable | (2,154,522 | ) | - | (2,154,522 | ) | - | ||||||||||
| Remeasurement (gain) loss on translation of foreign subsidiary | 7,578 | 3,870 | 8,990 | (5,113 | ) | |||||||||||
| Total other (income) expenses | (39,609 | ) | 749,024 | 1,043,290 | 1,849,634 | |||||||||||
| Net income before income taxes | 1,663,344 | 834,568 | 2,528,148 | 1,542,287 | ||||||||||||
| Income tax benefit (expense) | (190,107 | ) | (179,382 | ) | (178,647 | ) | (306,571 | ) | ||||||||
| Net income after tax | $ | 1,473,237 | $ | 655,186 | $ | 2,349,501 | $ | 1,235,716 | ||||||||
| Net income per share – basic | $ | 0.17 | $ | 0.09 | $ | 0.27 | $ | 0.17 | ||||||||
| Net income per share – diluted | $ | 0.17 | $ | 0.09 | $ | 0.27 | $ | 0.17 | ||||||||
| Weighted average common shares outstanding | ||||||||||||||||
| Basic | 8,928,548 | 7,373,745 | 8,743,639 | 7,373,745 | ||||||||||||
| Diluted | 8,928,548 | 7,373,745 | 8,743,639 | 7,373,745 | ||||||||||||
| Comprehensive income: | ||||||||||||||||
| Net income | 1,473,237 | 655,186 | 2,349,501 | 1,235,716 | ||||||||||||
| Foreign currency translation adjustment | 39,874 | 55,736 | 37,939 | 187,373 | ||||||||||||
| Comprehensive income | $ | 1,513,111 | $ | 710,922 | $ | 2,387,440 | $ | 1,423,089 | ||||||||
| Synergy CHC Corp. | ||||||||
| Unaudited Condensed Consolidated Statements of Cash Flows | ||||||||
| For the six | For the six | |||||||
| months ended | months ended | |||||||
| June 30, | June 30, | |||||||
| 2025 | 2024 | |||||||
| Cash Flows from Operating Activities | ||||||||
| Net income | $ | 2,349,501 | $ | 1,235,716 | ||||
| Adjustments to reconcile net income to net cash used in operating activities: | ||||||||
| Amortization of debt discount and debt issuance cost | 892,435 | - | ||||||
| Depreciation and amortization | 66,667 | 66,667 | ||||||
| Stock based compensation | - | 4,611 | ||||||
| Stock issued for modification of notes payable | 847,062 | - | ||||||
| Foreign currency transaction loss (gain) | (9,068 | ) | 23,345 | |||||
| Remeasurement loss (gain) on translation of foreign subsidiary | 8,990 | (5,113 | ) | |||||
| Non cash implied interest | - | 4,799 | ||||||
| Gain on settlement of debt | (2,154,522 | ) | - | |||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (1,748,852 | ) | (1,161,992 | ) | ||||
| Other receivables | (25,457 | ) | - | |||||
| Loan receivable, related party | (52,824 | ) | 35,449 | |||||
| Inventory | (647,606 | ) | 1,805,950 | |||||
| Prepaid expenses | 283,848 | (276,818 | ) | |||||
| Prepaid expense, related party | (488,379 | ) | (326,682 | ) | ||||
| Income taxes payable | 23,495 | 262,374 | ||||||
| Contract liabilities | (19,365 | ) | (2,949 | ) | ||||
| Accounts payable and accrued liabilities | (610,770 | ) | (2,804,381 | ) | ||||
| Accounts payable, shareholder | 385,114 | (980 | ) | |||||
| Net cash used in operating activities | (899,731 | ) | (1,140,005 | ) | ||||
| Cash Flows from Investing Activities | - | - | ||||||
| Cash Flows from Financing Activities | ||||||||
| Advances from related party | 135,000 | 1,509,226 | ||||||
| Repayment of notes payable, related party | (135,000 | ) | (84,500 | ) | ||||
| Proceeds from notes payable | 18,996,250 | 600,000 | ||||||
| Payment of loan financing fees | (1,980,914 | ) | - | |||||
| Repayment of notes payable, shareholder | (10,000,000 | ) | - | |||||
| Repayment of notes payable | (5,382,903 | ) | (1,617,335 | ) | ||||
| Net cash provided by financing activities | 1,632,433 | 407,391 | ||||||
| Effect of exchange rate on cash, cash equivalents and restricted cash | 37,939 | 187,373 | ||||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | 770,641 | (545,241 | ) | |||||
| Cash and restricted cash, beginning of year | 787,920 | 732,534 | ||||||
| Cash and restricted cash, end of period | $ | 1,558,561 | $ | 187,293 | ||||
| Supplemental Disclosure of Cash Flow Information: | ||||||||
| Cash paid during the period for: | ||||||||
| Interest | $ | 896,734 | $ | 1,850,896 | ||||
| Income taxes | $ | - | $ | 44,197 | ||||
| Supplemental Disclosure of Noncash Investing and Financing Activities: | ||||||||
| Accounts payable converted to loan payable upon settlement | $ | - | $ | 3,770,824 | ||||
| Reduction of short term related party note payable by reduction of prepaid balance | $ | - | $ | 328,003 | ||||
| Issuance of common stock for loan financing | $ | 117,648 | $ | - | ||||
| Issuance of pre-funded warrants for settlement of shareholder notes payable | $ | 899,993 | $ | - | ||||
| Exercise of pre-funded warrants | $ | 4 | $ | - | ||||
| Loan fees payable to lender | $ | 375,000 | $ | - | ||||
FAQ
What were Synergy CHC Corp's (SNYR) Q2 2025 earnings results?
How much did Synergy CHC Corp's (SNYR) net income grow in Q2 2025?
What major financial transaction did Synergy CHC complete in Q2 2025?
How did Synergy's working capital position change in Q2 2025?
What international expansion did Synergy announce in Q2 2025?
